Combination Chemotherapy in Treating Women With Resected Breast Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug and giving them after surgery may kill
any tumor cells remaining after surgery. It is not yet known which combination chemotherapy
regimen is more effective in treating resected stage I or stage II breast cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of different combination
chemotherapy regimens in treating women who have resected stage I or stage II breast cancer.